On the use of the Pfizer and the Moderna COVID-19 mRNA vaccines in children and adolescents

This up-to-date document provides a comprehensive risk-benefit analysis of the use of the Pfizer and Moderna COVID-19 vaccines in children and adolescents. The document also addresses the risk of genotoxicity of the mRNA vaccines, which according to recent experimental evidence of their integration into host cell genomes must be considered urgent.